A subsequent retrospective analysis [ 7 ] demonstrated that the SVR cirrhotics had reduced rates of liver-related deaths, even if this result did not reach statistical significance (treated vs. untreated SVR 1/53 vs. non-SVR 15/177, 2% vs. 8%, P = 0.13).
← all excerpts
Treatment of patients with HCV related cirrhosis: many rewards with very few risks.
1
0.1300
0.1300